How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Buy
52
SMMNY Quote, Financials, Valuation and Earnings
Last price:
$26.92
Seasonality move
:
-3.21%
Day range:
$26.72 - $27.12
52-week range:
$23.28 - $30.19
Dividend yield:
3.75%
P/E ratio:
26.76x
P/S ratio:
2.42x
P/B ratio:
2.97x
Volume:
18.7K
Avg. volume:
58.8K
1-year change:
-9.63%
Market cap:
$60B
Revenue:
$24.3B
EPS (TTM):
$1.00
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
-- | -- | -- | -- | -- |
|
ATAI
ATAI Life Sciences NV
|
-- | -$0.12 | -100% | -69.44% | $9.83 |
|
BNTX
BioNTech SE
|
$172.6M | -$2.25 | 23.21% | -34.69% | $136.00 |
|
CVAC
CureVac NV
|
$3.9M | -$0.21 | -75.29% | -39.13% | $4.80 |
|
IFRX
InflaRx NV
|
$24.7K | -$0.23 | 256.48% | -10.49% | $3.62 |
|
IMTX
Immatics NV
|
$13M | -$0.36 | -35.38% | -96.4% | $14.33 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$26.75 | -- | $60B | 26.76x | $0.50 | 3.75% | 2.42x |
|
ATAI
ATAI Life Sciences NV
|
$2.65 | $9.83 | $530.9M | -- | $0.00 | 0% | 233.99x |
|
BNTX
BioNTech SE
|
$110.65 | $136.00 | $26.6B | 191.55x | $0.00 | 0% | 8.97x |
|
CVAC
CureVac NV
|
$5.41 | $4.80 | $1.2B | 5.99x | $0.00 | 0% | 2.12x |
|
IFRX
InflaRx NV
|
$0.81 | $3.62 | $55.1M | -- | $0.00 | 0% | 268.90x |
|
IMTX
Immatics NV
|
$5.96 | $14.33 | $724.4M | 42.21x | $0.00 | 0% | 4.35x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
0.59% | 0.834 | 0.2% | 0.70x |
|
ATAI
ATAI Life Sciences NV
|
13.53% | 5.441 | 8.75% | 3.50x |
|
BNTX
BioNTech SE
|
1.53% | 1.572 | 1.45% | 9.86x |
|
CVAC
CureVac NV
|
-- | 1.687 | -- | 7.39x |
|
IFRX
InflaRx NV
|
-- | 1.115 | -- | 3.85x |
|
IMTX
Immatics NV
|
-- | 0.442 | -- | 9.87x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SMMNY
Siemens Healthineers AG
|
$2.4B | $888.1M | 10.84% | 11.11% | 14.11% | $197.2M |
|
ATAI
ATAI Life Sciences NV
|
-- | -$20.3M | -81.4% | -92.32% | -1634.02% | -$18.1M |
|
BNTX
BioNTech SE
|
$104.2M | -$562M | -3.86% | -3.91% | -225.11% | -$1.5B |
|
CVAC
CureVac NV
|
$18.9K | -$57.6M | 32.68% | 32.68% | -5747.14% | -$44.1M |
|
IFRX
InflaRx NV
|
-$9.8K | -$13.7M | -56.78% | -56.78% | 1207051.66% | -$14.8M |
|
IMTX
Immatics NV
|
-- | -$37.2M | -4.67% | -4.67% | -218.49% | -$39.3M |
Siemens Healthineers AG vs. Competitors
-
Which has Higher Returns SMMNY or ATAI?
ATAI Life Sciences NV has a net margin of 8.97% compared to Siemens Healthineers AG's net margin of -1699.74%. Siemens Healthineers AG's return on equity of 11.11% beat ATAI Life Sciences NV's return on equity of -92.32%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG39.31% $0.25 $20.4B ATAIATAI Life Sciences NV-- -$0.15 $176.1M -
What do Analysts Say About SMMNY or ATAI?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand ATAI Life Sciences NV has an analysts' consensus of $9.83 which suggests that it could grow by 271.07%. Given that ATAI Life Sciences NV has higher upside potential than Siemens Healthineers AG, analysts believe ATAI Life Sciences NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 ATAIATAI Life Sciences NV7 0 0 -
Is SMMNY or ATAI More Risky?
Siemens Healthineers AG has a beta of 1.001, which suggesting that the stock is 0.13300000000001% more volatile than S&P 500. In comparison ATAI Life Sciences NV has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMMNY or ATAI?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.75%. ATAI Life Sciences NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. ATAI Life Sciences NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or ATAI?
Siemens Healthineers AG quarterly revenues are $6.2B, which are larger than ATAI Life Sciences NV quarterly revenues of $1.6M. Siemens Healthineers AG's net income of $557.7M is higher than ATAI Life Sciences NV's net income of -$26.4M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 26.76x while ATAI Life Sciences NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.42x versus 233.99x for ATAI Life Sciences NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.42x 26.76x $6.2B $557.7M ATAIATAI Life Sciences NV233.99x -- $1.6M -$26.4M
-
Which has Higher Returns SMMNY or BNTX?
BioNTech SE has a net margin of 8.97% compared to Siemens Healthineers AG's net margin of -227.46%. Siemens Healthineers AG's return on equity of 11.11% beat BioNTech SE's return on equity of -3.91%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG39.31% $0.25 $20.4B BNTXBioNTech SE54.16% -$1.82 $20.8B -
What do Analysts Say About SMMNY or BNTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $136.00 which suggests that it could grow by 22.91%. Given that BioNTech SE has higher upside potential than Siemens Healthineers AG, analysts believe BioNTech SE is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 BNTXBioNTech SE14 5 0 -
Is SMMNY or BNTX More Risky?
Siemens Healthineers AG has a beta of 1.001, which suggesting that the stock is 0.13300000000001% more volatile than S&P 500. In comparison BioNTech SE has a beta of 1.283, suggesting its more volatile than the S&P 500 by 28.318%.
-
Which is a Better Dividend Stock SMMNY or BNTX?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.75%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or BNTX?
Siemens Healthineers AG quarterly revenues are $6.2B, which are larger than BioNTech SE quarterly revenues of $192.3M. Siemens Healthineers AG's net income of $557.7M is higher than BioNTech SE's net income of -$437.5M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 26.76x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.42x versus 8.97x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.42x 26.76x $6.2B $557.7M BNTXBioNTech SE8.97x 191.55x $192.3M -$437.5M
-
Which has Higher Returns SMMNY or CVAC?
CureVac NV has a net margin of 8.97% compared to Siemens Healthineers AG's net margin of -5832.47%. Siemens Healthineers AG's return on equity of 11.11% beat CureVac NV's return on equity of 32.68%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG39.31% $0.25 $20.4B CVACCureVac NV2.02% -$0.24 $699.9M -
What do Analysts Say About SMMNY or CVAC?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $4.80 which suggests that it could fall by -11.24%. Given that CureVac NV has higher upside potential than Siemens Healthineers AG, analysts believe CureVac NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 CVACCureVac NV1 5 0 -
Is SMMNY or CVAC More Risky?
Siemens Healthineers AG has a beta of 1.001, which suggesting that the stock is 0.13300000000001% more volatile than S&P 500. In comparison CureVac NV has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMMNY or CVAC?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.75%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or CVAC?
Siemens Healthineers AG quarterly revenues are $6.2B, which are larger than CureVac NV quarterly revenues of $939.6K. Siemens Healthineers AG's net income of $557.7M is higher than CureVac NV's net income of -$54.8M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 26.76x while CureVac NV's PE ratio is 5.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.42x versus 2.12x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.42x 26.76x $6.2B $557.7M CVACCureVac NV2.12x 5.99x $939.6K -$54.8M
-
Which has Higher Returns SMMNY or IFRX?
InflaRx NV has a net margin of 8.97% compared to Siemens Healthineers AG's net margin of -14092.9%. Siemens Healthineers AG's return on equity of 11.11% beat InflaRx NV's return on equity of -56.78%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG39.31% $0.25 $20.4B IFRXInflaRx NV-5376.61% -$0.14 $63.9M -
What do Analysts Say About SMMNY or IFRX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $3.62 which suggests that it could grow by 344.48%. Given that InflaRx NV has higher upside potential than Siemens Healthineers AG, analysts believe InflaRx NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IFRXInflaRx NV5 1 0 -
Is SMMNY or IFRX More Risky?
Siemens Healthineers AG has a beta of 1.001, which suggesting that the stock is 0.13300000000001% more volatile than S&P 500. In comparison InflaRx NV has a beta of 1.291, suggesting its more volatile than the S&P 500 by 29.054%.
-
Which is a Better Dividend Stock SMMNY or IFRX?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.75%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IFRX?
Siemens Healthineers AG quarterly revenues are $6.2B, which are larger than InflaRx NV quarterly revenues of -$450. Siemens Healthineers AG's net income of $557.7M is higher than InflaRx NV's net income of -$8.7M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 26.76x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.42x versus 268.90x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.42x 26.76x $6.2B $557.7M IFRXInflaRx NV268.90x -- -$450 -$8.7M
-
Which has Higher Returns SMMNY or IMTX?
Immatics NV has a net margin of 8.97% compared to Siemens Healthineers AG's net margin of -214.48%. Siemens Healthineers AG's return on equity of 11.11% beat Immatics NV's return on equity of -4.67%.
Company Gross Margin Earnings Per Share Invested Capital SMMNYSiemens Healthineers AG39.31% $0.25 $20.4B IMTXImmatics NV-- -$0.35 $580.8M -
What do Analysts Say About SMMNY or IMTX?
Siemens Healthineers AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $14.33 which suggests that it could grow by 140.49%. Given that Immatics NV has higher upside potential than Siemens Healthineers AG, analysts believe Immatics NV is more attractive than Siemens Healthineers AG.
Company Buy Ratings Hold Ratings Sell Ratings SMMNYSiemens Healthineers AG0 0 0 IMTXImmatics NV7 0 0 -
Is SMMNY or IMTX More Risky?
Siemens Healthineers AG has a beta of 1.001, which suggesting that the stock is 0.13300000000001% more volatile than S&P 500. In comparison Immatics NV has a beta of 0.811, suggesting its less volatile than the S&P 500 by 18.925%.
-
Which is a Better Dividend Stock SMMNY or IMTX?
Siemens Healthineers AG has a quarterly dividend of $0.50 per share corresponding to a yield of 3.75%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Siemens Healthineers AG pays 54.74% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. Siemens Healthineers AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMMNY or IMTX?
Siemens Healthineers AG quarterly revenues are $6.2B, which are larger than Immatics NV quarterly revenues of $19.6M. Siemens Healthineers AG's net income of $557.7M is higher than Immatics NV's net income of -$41.9M. Notably, Siemens Healthineers AG's price-to-earnings ratio is 26.76x while Immatics NV's PE ratio is 42.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Siemens Healthineers AG is 2.42x versus 4.35x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMMNYSiemens Healthineers AG2.42x 26.76x $6.2B $557.7M IMTXImmatics NV4.35x 42.21x $19.6M -$41.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Oklo Stock Double?
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
Why a $5 Stock Is Suddenly a Cash Machine
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
78
SBET alert for Jul 16
SharpLink Gaming [SBET] is up 28.58% over the past day.
Buy
75
MP alert for Jul 16
MP Materials [MP] is up 0.48% over the past day.
Sell
38
NAIL alert for Jul 16
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 2.38% over the past day.
